A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: An independent validation study from the European Randomized Study of Prostate Cancer screening, France Academic Article uri icon

Overview

MeSH Major

  • Kallikreins
  • Prostatic Neoplasms

abstract

  • In this independent validation study, the model was highly predictive of prostate cancer in men for whom the decision to biopsy is based on both elevated PSA and clinical work-up. Use of this model would reduce a large number of biopsies while missing few cancers.

publication date

  • November 25, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2996396

Digital Object Identifier (DOI)

  • 10.1186/1471-2407-10-635

PubMed ID

  • 21092177

Additional Document Info

start page

  • 635

volume

  • 10